Members |
targetComponentId |
Bruises easily |
Does bruise easily (situation) |
Bruises easily |
Easy bruising (finding) |
Bruises easily |
Easy bruising (finding) |
Bruises with crushing - superficial injury |
Crushing injury |
Bruises with crushing - superficial injury |
Contusion |
Bruises with crushing - superficial injury |
Superficial injury |
Bruising in fetus OR newborn |
Neonatal bruising of scalp |
Brunfelsia species |
Brunfelsia (organism) |
Bubonocele |
Inguinal hernia (disorder) |
Bubonocele |
Bubonocele (disorder) |
Buccal smear for Barr bodies |
Buccal smear for Barr bodies |
Buccal smear for Barr bodies |
Buccal smear procedure |
Buccolabial muscle |
Structure of buccolabial muscle |
Buccolabial muscle |
Entire buccolabial muscle (body structure) |
Budesonide + formoterol fumarate 100/6mcg breath-actuated dry powder inhaler |
Budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
Budesonide 100micrograms aqueous nasal spray |
Budesonide 100 microgram/actuation nasal spray |
Budesonide 100micrograms breath-actuated dry powder inhaler |
Budesonide 100 microgram/actuation powder for inhalation |
Budesonide 200micrograms breath-actuated dry powder inhaler |
Budesonide 200 microgram/actuation powder for inhalation |
Budesonide 200micrograms inhalation capsule |
Budesonide 200 microgram/actuation powder for inhalation |
Budesonide 32mcg spray |
Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
Budesonide 32mcg/spray spray |
Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
Budesonide 32micrograms aqueous nasal spray |
Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug) |
Budesonide 3mg m/r capsule |
Product containing precisely budesonide 3 milligram/1 each gastro-resistant oral capsule (clinical drug) |
Budesonide 400micrograms breath-actuated dry powder inhaler |
Budesonide 400 microgram/actuation powder for inhalation |
Budesonide 400micrograms inhalation capsule |
Budesonide 400 microgram/actuation powder for inhalation |
Budesonide 50micrograms aqueous nasal spray |
Budesonide 50 microgram/actuation nasal spray |
Budesonide 7g inhaler |
Budesonide 50 microgram/actuation nasal spray |
Budesonide Topical |
Budesonide-containing product in cutaneous dose form |
Budesonide refill |
Product containing budesonide (medicinal product) |
Budesonide refill 100dose |
Product containing budesonide (medicinal product) |
Budesonide refill 200dose |
Product containing budesonide (medicinal product) |
Budesonide systemic preparation |
Product containing budesonide (medicinal product) |
Budesonide+eformoterol fumarate 200/6mcg breath-actuated dry powder inhaler |
Budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/actuation powder for inhalation |
Budgerigar radio-allergosorbent test |
Budgerigar serum proteins specific immunoglobulin E antibody measurement (procedure) |
Budgerigar radio-allergosorbent test |
Budgerigar serum proteins specific immunoglobulin E antibody measurement (procedure) |
Budgerigar radio-allergosorbent test |
Budgerigar feathers specific immunoglobulin E antibody measurement (procedure) |
Budgerigar radio-allergosorbent test |
Budgerigar droppings specific immunoglobulin E antibody measurement |
Budgerigar radio-allergosorbent test |
Budgerigar droppings specific immunoglobulin E antibody measurement |
Budgerigar radio-allergosorbent test |
Budgerigar serum proteins specific immunoglobulin E antibody measurement (procedure) |
Budgerigar radio-allergosorbent test |
Budgerigar droppings specific immunoglobulin E antibody measurement |
Budgerigar radio-allergosorbent test |
Budgerigar feathers specific immunoglobulin E antibody measurement (procedure) |
Budgerigar radio-allergosorbent test |
Budgerigar feathers specific immunoglobulin E antibody measurement (procedure) |
Budvicia species |
Budvicia |
Buff-throated woodhewer |
Xiphorhynchus guttatus (organism) |
Buffalo obesity |
Buffalo obesity |
Buffalo obesity |
Central obesity |
Building society manager (& [branch]) |
Building society manager |
Building society manager (& [branch]) |
Building society manager |
Building society manager (& [branch]) |
Building society branch manager |
Building society manager (& [branch]) |
Building society branch manager |
Bulbar conjunctival drainage bleb |
Disorder of filtering bleb (disorder) |
Bulbar conjunctival drainage bleb |
Functional filtering bleb (finding) |
Bulbar hemorrhage |
Hemorrhage of medulla oblongata (disorder) |
Bulbar hemorrhage |
Hemorrhage of medulla oblongata (disorder) |
Bulky uterus (& [NOS]) or enlarged uterus |
Bulky uterus |
Bulky uterus (& [NOS]) or enlarged uterus |
Enlarged uterus |
Bulky uterus (& [NOS]) or enlarged uterus |
Enlarged uterus |
Bulky uterus (& [NOS]) or enlarged uterus |
Bulky uterus |
Bulleidia species |
Bulleidia |
Bullfinch |
Genus Loxigilla (organism) |
Bullfinch |
Genus Pyrrhula (organism) |
Bullfinch |
Melopyrrha nigra (organism) |
Bullous erythema multiforme |
Erythema multiforme |
Bullous erythema multiforme |
A limited form of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum characterised by destruction and detachment of the skin epithelium, involving less than 10% of the body surface area, and mucous membranes. Onset usually occurs 4-28 days after administration of the causal medication and is most frequently associated with anticonvulsants, antibacterial sulfonamides, allopurinol, nevirapine, and oxicams (non-steroidal anti-inflammatory drugs), but many other medications have also been implicated. The disease is not induced by medication in 15% of cases. Histology is characterised by an epidermal necrolysis. Multiple disabling long-term sequelae (especially cutaneous, ocular and psychological) are frequent. |
Bumetanide 500micrograms/mL injection solution 4mL ampule |
Bumetanide 500 microgram/mL solution for injection |
Bumetanide+potassium 500mcg/7.7Mmol m/r tablet |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet |
Bungarus candidus |
Bungarus candidus |
Bunion |
Hallux valgus AND bunion |
Bunion |
Swelling of first metatarsophalangeal joint of hallux (disorder) |
Bunion of great toe |
Swelling of first metatarsophalangeal joint of hallux (disorder) |
Bunion of great toe |
Hallux valgus AND bunion |
Bunionectomy |
Excision of bunion |
Bunionectomy |
Silver bunionectomy |
Bunionectomy with soft tissue correction |
McBride operation |
Bunionectomy with soft tissue correction |
Bunionectomy with soft tissue correction |
Bunyavirus |
Family Bunyaviridae (organism) |
Bunyavirus |
Genus Orthobunyavirus (organism) |
Buphthalmos |
Primary congenital glaucoma (disorder) |
Buphthalmos |
Primary congenital glaucoma (disorder) |
Buphthalmos |
Buphthalmos (finding) |
Buphthalmos |
Buphthalmos (finding) |
Buphthalmos NOS |
Primary congenital glaucoma (disorder) |
Buphthalmos NOS |
Buphthalmos (finding) |
Buphthalmos with congenital keratoglobus |
Buphthalmos (finding) |
Buphthalmos with congenital keratoglobus |
Primary congenital glaucoma (disorder) |
Buphthalmos with congenital keratoglobus |
Congenital keratoglobus |
Buphthalmos with congenital lens dislocation |
Buphthalmos (finding) |
Buphthalmos with congenital lens dislocation |
Complete luxation of lens (disorder) |
Buphthalmos with megalocornea |
Buphthalmos (finding) |
Buphthalmos with megalocornea |
Megalocornea |
Buphthalmos with megalocornea |
Primary congenital glaucoma (disorder) |
Buphthalmos with other eye anomaly |
Primary congenital glaucoma (disorder) |
Buphthalmos with other eye anomaly |
Buphthalmos (finding) |
Buphthalmos with other eye anomaly NOS |
Primary congenital glaucoma (disorder) |
Buphthalmos with other eye anomaly NOS |
Buphthalmos (finding) |
Buphthalmos, unspecified |
Primary congenital glaucoma (disorder) |
Buphthalmos, unspecified |
Buphthalmos (finding) |
Bupivacaine + dextrose |
Product containing bupivacaine (medicinal product) |
Bupivacaine 2.5mg/mL(0.25%) injection solution 10mL ampule |
Bupivacaine hydrochloride 2.5 mg/mL solution for injection |
Bupivacaine 5mg/mL(0.5%) injection solution 10mL ampule |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Buprenorphine 300micrograms/mL injection solution 1mL ampule |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |